Literature DB >> 27009029

Shunt lock therapy with micafungin to treat shunt-associated Candida albicans meningitis in an infant.

Cinzia Auriti1, Fiammetta Piersigilli2, Maria Paola Ronchetti2, Francesca Campi2, Paolina Giuseppina Amante3, Marco Falcone4, Bianca Maria Goffredo5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27009029     DOI： 10.1093/jac/dkw072

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Editorial: Therapeutic Drug Monitoring (TDM): A Useful Tool for Pediatric Pharmacology Applied to Routine Clinical Practice.

Authors:  Raffaele Simeoli; Thomas P C Dorlo; Lidwien M Hanff; Alwin D R Huitema; Erwin Dreesen
Journal:  Front Pharmacol       Date:  2022-05-24       Impact factor: 5.988

Review 2.  Clinical Pharmacokinetics and Pharmacodynamics of Micafungin.

Authors:  Roeland E Wasmann; Eline W Muilwijk; David M Burger; Paul E Verweij; Catherijne A Knibbe; Roger J Brüggemann
Journal:  Clin Pharmacokinet       Date:  2018-03       Impact factor: 6.447

Review 3.  Advances in the Treatment of Mycoses in Pediatric Patients.

Authors:  Elias Iosifidis; Savvas Papachristou; Emmanuel Roilides
Journal:  J Fungi (Basel)       Date:  2018-10-11

Review 4.  Antifungal Drugs for Invasive Candida Infections (ICI) in Neonates: Future Perspectives.

Authors:  Iliana Bersani; Fiammetta Piersigilli; Bianca Maria Goffredo; Alessandra Santisi; Sara Cairoli; Maria Paola Ronchetti; Cinzia Auriti
Journal:  Front Pediatr       Date:  2019-09-20       Impact factor: 3.418
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.